Vesalius Therapeutics
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
140 1st St Ste 401, Cambridge, Massachus...Website
www.vesaliustx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Vesalius Therapeutics
Vesalius Therapeutics is a biotechnology company focused on redefining the treatment of common diseases that account for 90% of human illness, such as heart failure, type II diabetes, and Alzheimer's disease. The company employs a revolutionary platform that utilizes patient-derived experimental models and advanced data science, including AI and machine learning, to identify novel drug targets and develop effective treatments. Their approach emphasizes a patient-centric methodology, challenging traditional assumptions in disease diagnosis and treatment. Vesalius aims to advance innovative therapies by assembling a world-class team of scientists, technologists, and clinicians.Explore more
Vesalius Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Vesalius Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Vesalius Therapeutics recently announced quarterly report
Funding: Get notified immidiatlly once Vesalius Therapeutics has new funding data
Product Launch: Get notified when Vesalius Therapeutics launches new products
Check if Vesalius Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Check out if Vesalius Therapeutics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Vesalius Therapeutics
Click to see if Vesalius Therapeutics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Vesalius Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Vesalius Therapeutics
Compare insights from companies similar to Vesalius Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Vesalius Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Vesalius Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Vesalius Therapeutics.
Vesalius Therapeutics Tech Stack
A closer look at the technologies used by Vesalius Therapeutics
Most Recent Scoops
Open Position
New Hire
Executive Move
Executive Moves, New Hire
Open Position
Event
Product Marketing, Events, Training, Sales, Learning & Development, Search, Laboratory Operations, Medical Education & Training, Medical Research, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Technology, HR Operations, Operations
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Vesalius Therapeutics
Sign Up For FreeTo access detailed company insights
Vesalius Therapeutics is a biotechnology company focused on redefining the treatment of common diseases that account for 90% of human illness, such as heart failure, type II diabetes, and Alzheimer's disease. The company employs a revolutionary platform that utilizes patient-derived experimental models and advanced data science, including AI and ma... Read More
